63 min 12 sec
Can CAR T therapy address the unmet need in patients with 3L+ R/R MCL post-BTKi?
Watch here the replay of this webinar, where an expert panel will discuss key Tecartus clinical and real-world data in patients with 3L+ R/R MCL post-BTKi, as well as discuss key patient case studies. The faculty are Dr Gloria Iacaboni, Consultant Haematologist, Vall d'Hebron Hospital, Barcelona, Spain and Professor Sascha Dietrich, Senior Physician, Heidelberg University Hospital, Germany.
Sign in
This website is only accessible for Healthcare Professionals who are allowed to prescribe Gilead’s medicinal products. The below mentioned personal data will only be processed for the purpose of verifying your rights to access this part of the website. More information about the processing of your personal data can be found here: website privacy statement english - french - dutch.
Please fill in your username and password to enter the Cell Therapy knowledge hub.
Need an account? Sign up here!
This website is only accessible for Healthcare Professionals who are allowed to prescribe Gilead’s medicinal products. The below mentioned personal data will only be processed for the purpose of verifying your rights to access this part of the website. More information about the processing of your personal data can be found here: website privacy statement english - french - dutch.
To improve the provision of our service to you, we will use your information to create your personalized account and tailor your web experience in accordance with our privacy policy.
Already have an account? Click here
Forgotten Password
